The annual impact of seasonal influenza in the US: measuring disease burden and costs.

PubWeight™: 9.96‹?› | Rank: Top 0.1%

🔗 View Article (PMID 17544181)

Published in Vaccine on April 20, 2007

Authors

Noelle-Angelique M Molinari1, Ismael R Ortega-Sanchez, Mark L Messonnier, William W Thompson, Pascale M Wortley, Eric Weintraub, Carolyn B Bridges

Author Affiliations

1: Immunization Service Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mail-Stop E-88, Atlanta, GA 30333, USA. NMolinari@cdc.gov

Associated clinical trials:

Kent State University / Price Chopper Employee Wellness Study | NCT03454009

Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform | NCT04525118

A Digital Flu Intervention for People With Cardiovascular Conditions (CardioFlu) | NCT04584645

Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform | NCT04663776

Articles citing this

(truncated to the top 100)

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother (2008) 5.04

Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. Am J Epidemiol (2009) 2.47

Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008. PLoS One (2009) 2.38

Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst (2008) 2.23

Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev (2011) 2.22

Human infections with avian influenza A(H7N9) virus in China: preliminary assessments of the age and sex distribution. Western Pac Surveill Response J (2013) 2.10

Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS One (2008) 2.04

Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect (2008) 1.88

Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis (2011) 1.87

Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis (2010) 1.86

Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008. PLoS One (2009) 1.85

Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol (2013) 1.75

Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008-2010. Bull World Health Organ (2011) 1.74

The burden of influenza B: a structured literature review. Am J Public Health (2013) 1.69

Prioritization of influenza pandemic vaccination to minimize years of life lost. J Infect Dis (2008) 1.69

Economics of influenza vaccine administration timing for children. Am J Manag Care (2010) 1.65

Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses. Vaccine (2011) 1.59

The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat Immunol (2014) 1.57

Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania. BMC Public Health (2011) 1.56

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infect Dis (2010) 1.53

The complex relationship of realspace events and messages in cyberspace: case study of influenza and pertussis using tweets. J Med Internet Res (2013) 1.51

Comparison of filtering methods for the modeling and retrospective forecasting of influenza epidemics. PLoS Comput Biol (2014) 1.47

Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients. Ann Emerg Med (2013) 1.47

Randomized controlled trial of the effect of regular paracetamol on influenza infection. Respirology (2015) 1.47

Excess mortality in Europe following a future Laki-style Icelandic eruption. Proc Natl Acad Sci U S A (2011) 1.44

Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg Infect Dis (2010) 1.43

Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog (2012) 1.43

Are well-child visits a risk factor for subsequent influenza-like illness visits? Infect Control Hosp Epidemiol (2014) 1.42

The reliability of tweets as a supplementary method of seasonal influenza surveillance. J Med Internet Res (2014) 1.39

Planning influenza vaccination programs: a cost benefit model. Cost Eff Resour Alloc (2012) 1.39

Viral etiology of influenza-like illnesses in Antananarivo, Madagascar, July 2008 to June 2009. PLoS One (2011) 1.38

Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother (2009) 1.37

Statewide school-located influenza vaccination program for children 5-13 years of age, Hawaii, USA. Emerg Infect Dis (2010) 1.35

The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Clin Microbiol Infect (2012) 1.34

At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol (2014) 1.33

Global disease monitoring and forecasting with Wikipedia. PLoS Comput Biol (2014) 1.33

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. Antimicrob Agents Chemother (2010) 1.29

Influenza vaccination among healthcare workers: ten-year experience of a large healthcare organization. Infect Control Hosp Epidemiol (2010) 1.28

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med (2009) 1.28

Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. J Virol (2014) 1.26

Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR. PLoS One (2010) 1.26

The economic value of a quadrivalent versus trivalent influenza vaccine. Vaccine (2012) 1.24

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health (2012) 1.23

Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza. Vaccine (2010) 1.19

Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine (2011) 1.19

A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 14, 2011. Public Health Rep (2012) 1.18

Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. Proc Natl Acad Sci U S A (2014) 1.17

A composite epidemic curve for seasonal influenza in Canada with an international comparison. Influenza Other Respir Viruses (2010) 1.17

Estimated incidence of influenza-virus-associated severe pneumonia in children in El Salvador, 2008-2010. Bull World Health Organ (2012) 1.17

In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen. Viruses (2014) 1.17

Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One (2015) 1.14

Most influenza a virions fail to express at least one essential viral protein. J Virol (2013) 1.14

Cost-effectiveness of adjuvanted versus nonadjuvanted influenza vaccine in adult hemodialysis patients. Am J Kidney Dis (2011) 1.14

The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. AIDS (2011) 1.14

Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection. Sci Rep (2012) 1.14

Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host Microbe (2013) 1.13

Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza Other Respir Viruses (2015) 1.13

Influenza A viruses dual and multiple infections with other respiratory viruses and risk of hospitalisation and mortality. Influenza Other Respir Viruses (2012) 1.13

High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination. Clin Immunol (2014) 1.12

Role of the primary care safety net in pandemic influenza. Am J Public Health (2009) 1.11

The geographic synchrony of seasonal influenza: a waves across Canada and the United States. PLoS One (2011) 1.10

Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade. Clin J Am Soc Nephrol (2010) 1.08

A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir Viruses (2008) 1.07

Burden of paediatric influenza in Western Europe: a systematic review. BMC Public Health (2012) 1.07

The Saudi Thoracic Society guidelines for influenza vaccinations. Ann Thorac Med (2015) 1.06

Modeling seasonal influenza outbreak in a closed college campus: impact of pre-season vaccination, in-season vaccination and holidays/breaks. PLoS One (2010) 1.06

Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City. J Urban Health (2011) 1.05

Influenza surveillance among outpatients and inpatients in Morocco, 1996-2009. PLoS One (2011) 1.05

From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine (2011) 1.05

Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. Eur J Clin Microbiol Infect Dis (2010) 1.05

Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave. BMC Public Health (2010) 1.05

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging (2012) 1.04

Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine (2010) 1.04

Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013. J Prim Prev (2015) 1.03

Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J Infect Dis (2012) 1.03

Viva la revolución: rethinking influenza a virus antigenic drift. Curr Opin Virol (2011) 1.02

Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development. J Virol (2014) 1.02

Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr Top Microbiol Immunol (2015) 1.02

Influenza A viral replication is blocked by inhibition of the inositol-requiring enzyme 1 (IRE1) stress pathway. J Biol Chem (2011) 1.01

Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev Vaccines (2012) 1.01

Modeling the effect of transient populations on epidemics in Washington DC. Sci Rep (2013) 1.01

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens. Mol Ther (2013) 1.00

An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands. Influenza Other Respir Viruses (2013) 1.00

Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses. Sci Transl Med (2013) 0.99

Economic burden of influenza-associated hospitalizations and outpatient visits in Bangladesh during 2010. Influenza Other Respir Viruses (2014) 0.99

Flexible Modeling of Epidemics with an Empirical Bayes Framework. PLoS Comput Biol (2015) 0.98

Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study. PLoS One (2012) 0.98

A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes. PLoS One (2011) 0.97

Comparison of a multiplex real-time PCR assay with a multiplex Luminex assay for influenza virus detection. J Clin Microbiol (2013) 0.97

Evolution of H3N2 influenza virus in a guinea pig model. PLoS One (2011) 0.97

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years. BMC Infect Dis (2013) 0.96

Evaluation of the Alere I influenza A&B nucleic acid amplification test by use of respiratory specimens collected in viral transport medium. J Clin Microbiol (2014) 0.96

Effect of influenza vaccines against mismatched strains: a systematic review protocol. Syst Rev (2012) 0.96

Biological activities of 'noninfectious' influenza A virus particles. Future Virol (2014) 0.95

Annual economic impacts of seasonal influenza on US counties: spatial heterogeneity and patterns. Int J Health Geogr (2012) 0.95

Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. PLoS One (2011) 0.94

Standardization of Nucleic Acid Tests for Clinical Measurements of Bacteria and Viruses. J Clin Microbiol (2014) 0.94

The cost of acute respiratory infections in Northern India: a multi-site study. BMC Public Health (2015) 0.94

Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. Eur J Health Econ (2014) 0.94

Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom. BMC Infect Dis (2015) 0.94

Articles by these authors

Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75

Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61

Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med (2009) 16.13

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59

Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 9.06

The underrecognized burden of influenza in young children. N Engl J Med (2006) 8.25

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2008) 6.18

Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J Infect Dis (2002) 5.92

Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2004) 5.00

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2005) 3.50

HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr (2002) 3.43

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol (2007) 3.33

The role of attitudes in understanding disparities in adult influenza vaccination. Am J Prev Med (2006) 3.29

The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis (2004) 2.96

Recent resurgence of mumps in the United States. N Engl J Med (2008) 2.90

Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr (2013) 2.86

Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses (2009) 2.82

Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis (2009) 2.80

Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis (2006) 2.79

Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 2.56

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics (2010) 2.39

Health care-associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis (2011) 2.36

Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics (2010) 2.32

Influenza- and RSV-associated hospitalizations among adults. Vaccine (2006) 2.23

Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review. PLoS One (2011) 2.22

Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2013) 2.20

Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics (2004) 2.08

The effect of universal influenza immunization on mortality and health care use. PLoS Med (2008) 2.01

Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis (2006) 1.96

Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine (2008) 1.91

Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Arch Pediatr Adolesc Med (2005) 1.88

Mental health surveillance among children--United States, 2005-2011. MMWR Surveill Summ (2013) 1.88

Factors associated with vaccination of medicare beneficiaries in five U.S. communities: Results from the racial and ethnic adult disparities in immunization initiative survey, 2003. J Am Geriatr Soc (2006) 1.79

Vaccination coverage among adults, excluding influenza vaccination - United States, 2013. MMWR Morb Mortal Wkly Rep (2015) 1.78

Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin Infect Dis (2010) 1.76

Gaps in vaccine financing for underinsured children in the United States. JAMA (2007) 1.75

Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med (2006) 1.75

Noninfluenza vaccination coverage among adults - United States, 2012. MMWR Morb Mortal Wkly Rep (2014) 1.74

Estimating influenza-associated deaths in the United States. Am J Public Health (2009) 1.73

Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin Vaccine Immunol (2007) 1.70

The burden of influenza in young children, 2004-2009. Pediatrics (2013) 1.68

Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA (2005) 1.67

A multisite study of the prevalence of HIV with rapid testing in mental health settings. Am J Public Health (2014) 1.67

Real-time vaccine safety surveillance for the early detection of adverse events. Med Care (2007) 1.66

Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine (2006) 1.65

Seasonal influenza vaccines. Curr Top Microbiol Immunol (2009) 1.63

Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics (2008) 1.63

The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics (2011) 1.60

Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Clin Infect Dis (2008) 1.60

Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic. Emerg Infect Dis (2007) 1.59

Guillain-Barré syndrome following influenza vaccination. JAMA (2004) 1.59

Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis (2006) 1.57

Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics (2008) 1.56

Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis (2002) 1.54

Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics (2007) 1.54

Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol (2011) 1.52

Influenza and pneumococcal vaccination of adults aged > or = 65: racial/ethnic differences. Am J Prev Med (2005) 1.52

Institutional requirements for influenza vaccination of healthcare personnel: results from a nationally representative survey of acute care hospitals--United States, 2011. Clin Infect Dis (2011) 1.51

Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons. MMWR Surveill Summ (2013) 1.50

Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties--2002-2009. Am J Epidemiol (2013) 1.50

Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis (2013) 1.49

Cost-effectiveness of using 2 vs 3 primary doses of 13-valent pneumococcal conjugate vaccine. Pediatrics (2013) 1.46

Medical care capacity for influenza outbreaks, Los Angeles. Emerg Infect Dis (2002) 1.46

FluSurge--a tool to estimate demand for hospital services during the next pandemic influenza. Med Decis Making (2006) 1.43

Estimating influenza hospitalizations among children. Emerg Infect Dis (2006) 1.41

Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7-10 years. Pharmacoepidemiol Drug Saf (2013) 1.40

Student immunity requirements of health professional schools: vaccination and other means of fulfillment-United States, 2008. Infect Control Hosp Epidemiol (2011) 1.39

Financial barriers to the adoption of combination vaccines by pediatricians. Arch Pediatr Adolesc Med (2010) 1.39

Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry (2011) 1.38

Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness. Pharmacoeconomics (2008) 1.35

Racial and ethnic disparities in influenza vaccination coverage among adults during the 2004-2005 season. Am J Epidemiol (2006) 1.33

Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J (2010) 1.32

U.S. physicians' perspective of adult vaccine delivery. Ann Intern Med (2014) 1.31

Comparison of racial/ethnic disparities in adult immunization and cancer screening. Am J Prev Med (2005) 1.25

Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics (2013) 1.25

Adolescent vaccination-coverage levels in the United States: 2006-2009. Pediatrics (2011) 1.24

Immunization information systems to increase vaccination rates: a community guide systematic review. J Public Health Manag Pract (2015) 1.23

Racial similarities in response to standardized offer of influenza vaccination. A MetroNet study. J Gen Intern Med (2006) 1.20

Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. J Infect Dis (2011) 1.20

Seasonal influenza vaccination coverage among adult populations in the United States, 2005-2011. Am J Epidemiol (2013) 1.17

High costs of influenza: Direct medical costs of influenza disease in young children. Vaccine (2010) 1.17

Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014. MMWR Surveill Summ (2016) 1.16

Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics (2005) 1.15

Influenza vaccination trends among adults 65 years or older in the United States, 1989-2002. Arch Intern Med (2005) 1.15

Influenza vaccination attitudes and practices among US registered nurses. Am J Infect Control (2009) 1.13

Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses. Clin Infect Dis (2003) 1.10

Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics (2010) 1.09

Increases in vaccination coverage of healthcare personnel following institutional requirements for influenza vaccination: a national survey of U.S. hospitals. Vaccine (2011) 1.09

Transmission of influenza A viruses between pigs and people, Iowa, 2002-2004. Influenza Other Respir Viruses (2010) 1.09

Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine (2009) 1.09